NICE today announced the appointment of Dr Adrian Hayter as its
new chief medical officer, bolstering the institute's clinical
leadership, following the appointment of CEO Professor Jonathan
Benger earlier this year.
Dr Hayter brings more than three decades of frontline clinical
and national leadership experience to the role, spanning general
practice, NHS commissioning and national clinical leadership.
A practising GP at Runnymede Medical Practice, Dr Hayter will
next year celebrate 30 years as a GP Partner, reflecting his
longstanding commitment to primary care.
Dr Adrian Hayter, incoming Chief medical officer at NICE,
said: "I am honoured to be joining NICE as chief medical
officer at such a critical time for health and care.
"As a GP, I rely on NICE guidance every day to make sure my
patients receive the best evidence-based care, from prescribing
decisions to managing long-term conditions.
"I know first-hand how vital it is that NICE's guidance is not
only independent, but developed in a way that allows clinicians
to deliver the best possible care, and I am committed to ensuring
NICE continues to play its full part in a health system that must
keep evolving to meet the needs of patients and the public.
"My ambition is to ensure NICE continues to drive innovation into
the hands of clinicians and commissioners, delivering real
improvements in health outcomes while making the best use of the
resources available to the NHS."
Professor Jonathan Benger CBE, Chief Executive of NICE,
said: "I am delighted to welcome Adrian to NICE as our
new chief medical officer.
“His breadth of experience, combining clinical practice and
national leadership, makes him exceptionally well placed to help
us deliver on our ambitions.
“As NICE expands its role under the 10 Year Health Plan, our
ability to deliver for patients will depend on the strength of
our relationships with the royal colleges, professional bodies
and our key system partners, including NHS England, the MHRA and
the CQC.
“Adrian's ability to forge and sustain those relationships will
be invaluable as we work together to get the best evidence-based
care to patients fast, while ensuring value for the taxpayer."
Over the course of his career, Dr Hayter has held a series of
significant leadership roles. He chaired the Windsor, Ascot and
Maidenhead Clinical Commissioning Group between 2013 and 2018,
and in 2019 became the first GP to be appointed as National
Clinical Director for Older People and Person-Centred Care by NHS
England – a role he held throughout the Covid pandemic.
He is a visiting Professor of Gerontology at Singapore University
of Social Science and is currently Medical Director for Clinical
Policy at the Royal College of General Practitioners (RCGP),
where he supported a network of GPs influencing the clinical
policy agenda across the four nations.
As the NHS shifts towards neighbourhood-based, person-centred
care, Dr Hayter's combination of clinical experience and
strategic leadership makes him ideally placed to guide NICE
through the next phase of its transformation.
From this month, NICE will extend its technology appraisal
process which requires the NHS to fund approved high-impact
healthtech that meets the NHS's most urgent needs, while a new
joint process with the MHRA will accelerate patient access to
medicines by up to six months.
Beyond technology, NICE will continually re-evaluate clinical
pathways on a rolling basis, identifying where older treatments
no longer represent good value and freeing up NHS budgets for new
innovations, ensuring every pound spent delivers the greatest
possible benefit to patients.
ENDS
Notes to editors:
- Dr Adrian Hayter will start at NICE in June when he will
leave his role at the RCGP.
